Industry News

- Read more about Cipla appoints Umang Vohra and Prabir Jha to its management team
Cipla Ltd, a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients, is announced the appointment of Umang Vohra as Global Chief Financial and Strategy Officer and Prabir Jha as Global Chief People Officer effective 1st October 2015.
- Read more about Cipla to acquire 100% of generic businesses in US for $550M
~ Through the acquisition of InvaGen, Cipla gains scale in the US generics market with a strong manufacturing and R&D base, access to broad product portfolio and a strong customer base consisting of top wholesalers/retailers
~ Through the acquisition of Exelan, Cipla gains access to the government and institutional market in the US

Cipla, a global pharmaceutical company which uses technology and innovation to meet the everyday needs of all patients, today announced that its UK arm, Cipla EU has entered into definitive agreements to acquire two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan Pharmaceuticals Inc. The transaction being subject to certain closing conditions, is valued at $550 million and will be an all cash transaction. The combined revenue from these transactions is over $200 million for the year ended Dec 2014 and over $225 million in LTM June 2015.
- Read more about Sun Pharma and Wockhardt recall their drugs from US market
Voluntary recall of a number of drugs have been initiated by Sun Pharma and Wockhardt from the US market due to different reasons.

Sun Pharma initiated voluntary recall of multiple lots of Bupropion Hydrochloride Extended-release Tablets USP (SR), 200 mg, 60-count bottle for "failed dissolution specification", while Wockhardt started recalling its Lisinopril Tablets USP, 5 mg and 20 mg for "CGMP violations".
- Read more about Mankind Pharma’s conduct ‘D3 Must Campaign’
The Mankind Pharma has taken an initiative to spread awareness about the importance of having strong bones, among the masses. The company has been championing this cause with their specialized ‘D3 Must Campaign’ across the country by reaching out to various schools, institutes and corporates.
- Read more about Mylan launch generic Zosyn inj in US markets
Mylan N.V., a global pharmaceutical company in US launch of Piperacillin and Tazobactam for injection USP, 3.375g single-dose vials, the generic version of Pfizer's Zosyn injection.
- Read more about Sun Pharma acquired Opiates business from GSK in Australia
Sun Pharmaceutical Industries Ltd today begins the integration of its Opiates business in Australia following the successful completion of this acquisition from GSK (announced in March 2015).

[adsense:336x280:8701650588]
- Read more about Siemens launched three new haematology systems
Siemens Healthcare has launched three new scalable haematology systems: the ADVIA 360 System, ADVIA 560 System and ADVIA 560 AL System.
The systems offer fast, high quality CBC testing, running up to 60 samples per hour. Automatic anti-clogging and cleaning procedures are employed to ensure results reliability. Along with automated maintenance, this reduces manual procedures and biohazard exposure. Other features include option for manual or automatic calibration procedures, a cap-piercing function for accurate and safer sampling, a multilingual operating menu and bidirectional LIS communication for easy patient data transfer between laboratories and minimised paper-based work lists.
- Read more about Roche acquires Lumora’s heat elution technology
Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical research and industrial markets, has sold its proprietary nucleic acid heat elution purification technology to Roche. Roche has signed a definitive asset purchase agreement with Lumora for products associated with its proprietary nucleic acid heat elution purification technology that is designed for use with clinical specimens.
- Read more about Pfizer receive US FTC clearance for Hospira acquisition
Pfizer Inc, one of the world's premier innovative biopharmaceutical companies, announced that the US Federal Trade Commission terminated the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, with respect to company's pending acquisition of Hospira.
- Read more about India’s First Health Exchange Website Zigy.com Connects People to Chemists
A health exchange portal called Zigy.com was launched by former iGate CEO Phaneesh Murthy-founded PM Health and Life Care (PMHLC) on August 24. Zigy.com connects patients requiring health products and services with doctors, hospitals, chemists, diagnostic labs and also provides wellness products and services, insurance, home-care services and alternative medicines. However, Zigy does not allow patients to order medicines without a genuine prescription. Zigy.com is availabe as a website and a mobile app as well.